Efficacy and Safety of Tralokinumab Treatment in Adults of Different Racial Subgroups With Moderate-to-Severe Atopic Dermatitis in Three Randomized, Placebo-Controlled Phase 3 Trials. J of Skin 2022, 6 (6), s76. https://doi.org/10.25251/skin.6.supp.76.